Gland Pharma Limited
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. We operate primarily under a business to business (B2B) model…
What Gland files
- Others76
- Investor Meet74
- Important27
- Updates23
- Board Meeting11
- PPTs6
Gland Pharma's Board declared a final dividend of ₹20 per equity share for FY26. The record date to determine eligibility for this dividend is August 11, 2026. Shareholders must hold shares by this date. The dividend, pending approval at the Annual General Meeting on August 25, 2026, will be paid...
Gland Pharma has announced a board meeting on August 14, 2025, as the record date for final dividend eligibility of ₹18 per share for FY25, pending approval at the 47th AGM on August 28, 2025. The company posted consolidated revenue of ₹561.65 billion for FY25, down 1% YoY, with PAT...